316.87

+0.53%↑

CAT

583.85

-0.46%↓

RTX

186.47

+0.19%↑

GEV.US

666.46

+1.29%↑

218.44

+1.26%↑

316.87

+0.53%↑

CAT

583.85

-0.46%↓

RTX

186.47

+0.19%↑

GEV.US

666.46

+1.29%↑

218.44

+1.26%↑

316.87

+0.53%↑

CAT

583.85

-0.46%↓

RTX

186.47

+0.19%↑

GEV.US

666.46

+1.29%↑

218.44

+1.26%↑

316.87

+0.53%↑

CAT

583.85

-0.46%↓

RTX

186.47

+0.19%↑

GEV.US

666.46

+1.29%↑

218.44

+1.26%↑

316.87

+0.53%↑

CAT

583.85

-0.46%↓

RTX

186.47

+0.19%↑

GEV.US

666.46

+1.29%↑

218.44

+1.26%↑

Home・Aandelen Lijst・India Globalization Capital Inc

India Globalization Capital Inc

Gesloten

0.29

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

0.29

Max

0.29

Belangrijke statistieken
By Trading Economics
Inkomsten	-222K -1.8M
Verkoop	-137K 191K
Winstmarge	-953.403
Werknemers	70
EBITDA	62K -1.7M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+1483.33% upside

Dividenden
By Dow Jones
Volgende Winsten	11 feb 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-6.9M 28M
Vorige openingsprijs	0.29
Vorige sluitingsprijs	0.29

India Globalization Capital Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

24 dec 2025, 21:41 UTC

Acquisities, Fusies, Overnames

Nvidia to Buy Chip-Designer Groq for $20 Billion, CNBC Reports

24 dec 2025, 14:57 UTC

Acquisities, Fusies, Overnames

Accenture to Acquire Cabel Industry from Fibonacci Group

24 dec 2025, 12:48 UTC

Belangrijke Marktbewegers

Acquisities, Fusies, Overnames

Repare Therapeutics Shares Rise on $30 Million Asset Deal With Gilead

24 dec 2025, 12:21 UTC

Belangrijke Marktbewegers

Nike Shares Tick Up After Apple CEO Tim Cook Buys $2.9 Million of Its Stock

24 dec 2025, 22:22 UTC

Acquisities, Fusies, Overnames

Nvidia, Groq Strike AI Tech Licensing Deal -- Barrons.com

24 dec 2025, 21:26 UTC

Acquisities, Fusies, Overnames

Nvidia to Buy Chip-Designer Groq for $20B, CNBC Reports

24 dec 2025, 19:35 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

24 dec 2025, 19:35 UTC

Marktinformatie

Treasury Yields Decline Ahead of Christmas -- Market Talk

24 dec 2025, 19:09 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Global Equities Roundup: Market Talk

24 dec 2025, 19:09 UTC

Marktinformatie

Acquisities, Fusies, Overnames

ServiceNow's Armis Acquisition Shouldn't Fuel Fears That Seat-Based Model Threatened -- Market Talk

24 dec 2025, 19:06 UTC

Marktinformatie

Oil Futures Little Changed in Light Pre-Holiday Trade -- Market Talk

24 dec 2025, 19:03 UTC

Marktinformatie

U.S. Natural Gas Futures Give Back Some Gains -- Market Talk

24 dec 2025, 17:20 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Tech, Media & Telecom Roundup: Market Talk

24 dec 2025, 17:20 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

24 dec 2025, 17:08 UTC

Acquisities, Fusies, Overnames

This Biotech Stock Soars 39%. Sanofi Is Buying It for $2.2 Billion. -- Barrons.com

24 dec 2025, 16:53 UTC

Acquisities, Fusies, Overnames

Nike Climb Boosts Dow, S&P 500 -- WSJ

24 dec 2025, 16:31 UTC

Marktinformatie

Acquisities, Fusies, Overnames

ServiceNow Gets Top-Tier Asset and Talent With Armis Buy -- Market Talk

24 dec 2025, 16:28 UTC

Acquisities, Fusies, Overnames

Lam Research Is at All-Time Highs. Its CEO Just Sold $27 Million Worth of Stock. -- Barrons.com

24 dec 2025, 16:17 UTC

Marktinformatie

Dollar Stable as U.S. Layoffs Remain at Bay -- Market Talk

24 dec 2025, 15:33 UTC

Acquisities, Fusies, Overnames

Nike Shares Get a Lift After Apple's Tim Cook Doubles His Personal Stake -- WSJ

24 dec 2025, 15:30 UTC

Acquisities, Fusies, Overnames

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

24 dec 2025, 15:19 UTC

Acquisities, Fusies, Overnames

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

24 dec 2025, 14:49 UTC

Acquisities, Fusies, Overnames

Mexico's Ollamani Sells Stake in Azteca Stadium

24 dec 2025, 14:19 UTC

Marktinformatie

U.S. Natural Gas Futures Move Lower After Big Jump -- Market Talk

24 dec 2025, 14:08 UTC

Acquisities, Fusies, Overnames

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

24 dec 2025, 14:06 UTC

Marktinformatie

Oil Futures Edge Up on Geopolitical Risk Premium -- Market Talk

24 dec 2025, 13:24 UTC

Marktinformatie

Canada's Economy Needs More Help Amid Dismal GDP Report -- Market Talk

24 dec 2025, 12:59 UTC

Acquisities, Fusies, Overnames

This Biotech Stock Is Soaring. Sanofi Is Buying It for $2.2 Billion. -- Barrons.com

24 dec 2025, 12:51 UTC

Acquisities, Fusies, Overnames

Disney Could Be the Real Winner from the Warner Takeover Battle. Here's Why. -- Barrons.com

24 dec 2025, 12:38 UTC

Acquisities, Fusies, Overnames

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

Peer Vergelijking

Prijswijziging

India Globalization Capital Inc Prognose

Koersdoel

By TipRanks

1483.33% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 4.75 USD 1483.33%

Hoogste 4.75 USD

Laagste 4.75 USD

Gebaseerd op 1 Wall Street-analisten die 12-maands prijsdoelen bieden voor India Globalization Capital Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

1 ratings

Buy

Hold

Sell

Gebaseerd op 1 analisten die aandelenratings hebben gegeven aan India Globalization Capital Inc - Dist in de afgelopen 3 maanden.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over India Globalization Capital Inc

IGC Pharma, Inc., a clinical stage pharmaceutical company, engages in developing treatments for Alzheimer's disease. The company's lead product is IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63, IGC-1C, IGC-M3, and LMP in pre-clinical development. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.